Update: Proposed Class Action Settlement Reached in Faulkner et al. v. Acella Pharmaceuticals, LLC

On February 7, 2024, the Court entered an Order Certifying Settlement Class and Preliminary Approving Settlement Agreement. Under the proposed class action settlement, if the settlement receives final approval, Acella will make financial benefits available to class members to resolve class members’ claims of economic damages. The value of the proposed settlement is estimated at approximately $46 million.  Class members will also retain any rights they may have to bring personal injury claims against Acella.

The class action administrator appointed by the Court will be making additional information available to class members in the near future. Once that website is running, we will provide a link to it. In the meantime, you may review key filings from the litigation below.

December 22, 2022 Court Order Granting Acella’s Partial Motion to Dismiss Plaintiff’s Complaint

July 10, 2023 Court Order Denying Acella’s Motion to Strike Class Allegations and to Stay Class Discovery

July 11, 2023 Court Order on Discovery Dispute 

February 2, 2024 Unopposed Motion for Preliminary Approval of Settlement Class and Memorandum in Support 

February 7, 2024 Court Order Certifying Settlement Class and Preliminary Approving Settlement Agreement

April 30, 2024 Unopposed Motion for Final Approval of Class Settlement and Memorandum in Support

April 30, 2024 Petition for Attorneys Fees and Costs and Memorandum in Support

May 16, 2024 Signed Order and Judgment Granting Final Approval of Settlement Class and Order Granting Petition for Attorneys’ Fees and Costs

Contact Us

Let us help you

    By submitting an email you are not creating an attorney-client relationship, but your submission is confidential.